GVK Biosciences, a contract research organization that conducts clinical trials for many reputed generic manufacturers in India and foreign countries is facing rough weather following the harsh recommendations made by the European Medicines Agency (EMA). The trouble started for GVK last May when ANSM, the French drug regulatory agency alleged data manipulation of “check-out ECGs”...